The pharmaceutical and life sciences industries face a unique set of challenges as their innovations in medications, biologics, medical devices, therapies, and techniques expand and evolve at an unprecedented pace. Stunning medical, scientific, and technological advancements have the potential to change or save the lives of millions. But they also have the potential to create catastrophic exposure for the companies which develop and bring these products to market.
Industry-Focused Knowledge and Experience
Traub Lieberman’s pharmaceutical and life sciences team recognizes both the promise and peril inherent in these industries. We provide sound counsel, robust advocacy, and comprehensive risk management strategies for a wide range of companies including manufacturers and distributors of name brand and generic pharmaceutical, medical device and biotech products; biologics and biosimilars; as well as over-the-counter products, nutraceuticals/nutritional supplements, and animal health products.
Our industry-focused attorneys have a deep understanding of the unique and nuanced legal, scientific, and business issues that pharmaceutical and life science companies face. We leverage that knowledge to develop and implement practical, cost-effective, and creative strategies designed to achieve the most favorable results for our clients.
We provide sophisticated and cost-effective representation in the following areas:
- Products liability
- Complex and multi-district litigation
- Claims management and resolution
- Commercial litigation
- Cyber-risk, technology, and data security
- Risk management
- Claim audits/due diligence
The Capabilities to Address Today's Claims and Prepare for Tomorrow's Challenges
From addressing informal demands through trial and appeal, Traub Lieberman’s attorneys have extensive experience handling the complex and consequential products liability and mass tort claims that frequently arise for industry players, including those involving catastrophic injuries and death from allegedly defective products, failures to warn, fraud, and related issues.
Combining our legal knowledge with a well-established and highly credentialed network of scientific and medical experts, we are adept at identifying key issues and assessing the potential exposure presented by such claims at the earliest stages. We then craft approaches for quick and efficient resolutions that insulate our clients from exposure or keep losses to a minimum. When an early conclusion to a matter is either not possible or not advisable, our seasoned litigators aggressively defend our clients at every stage.
Traub Lieberman’s multidisciplinary capabilities also manifest themselves in our pharma and life sciences practice. For example, our deep background in preventing, addressing, and remediating cyberattacks and data breaches makes us uniquely suited to help companies prepare for emerging risks from internet-enabled and connected implantable devices and technologies.
As a firm that built its reputation on the service and representation we provide to insurers, we have a assembled a claims audit and due diligence team that has decades of experience working with pharma/life science in-house legal departments. We evaluate significant losses as well as books of claims, identify and managing emerging trends, evaluate reserves, and collaborate with insurers and risk management teams to assess exposures for multiple purposes.
For pharmaceutical and life science companies and their insurers, Traub Lieberman has the capabilities to address today’s claims and help our clients be ready for tomorrow’s challenges.
